Literature DB >> 6775051

The inhibition of tyramine oxidation and the tyramine hypertensive response ("cheese effect") may be independent phenomena.

M Sandler, V Glover, A Ashford, A Esmail.   

Abstract

Although the selective monoamine oxidase (MAO) inhibitor, (-)-deprenyl, substantially inhibits tyramine-oxidizing ability in the pig, intravenous tyramine challenge after pretreatment with this drug failed to produce the characteristic pressor response ("cheese effect") associated with other irreversible MAO inhibitors. Conversely, pretreatment with the tyramine oxidation-sparing selective MAO inhibitor, clorgyline, followed by intravenous tyramine, paradoxically resulted in a profound pressor response. We suggest that the action of standard MAO-inhibiting drugs may be compounded of two separate actions, usually associated but, in fact, unreleated.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6775051     DOI: 10.1007/bf01250659

Source DB:  PubMed          Journal:  J Neural Transm            Impact factor:   3.575


  15 in total

1.  The output of sympathetic transmitter from the spleen of the cat.

Authors:  G L BROWN; J S GILLESPIE
Journal:  J Physiol       Date:  1957-08-29       Impact factor: 5.182

2.  The monoamine oxidase inhibitor, phenelzine, in the treatment of depressive -anxiety states. A controlled clinical trial.

Authors:  D S Robinson; A Nies; C L Ravaris; K R Lamborn
Journal:  Arch Gen Psychiatry       Date:  1973-09

3.  Effects of drugs on human blood platelet and plasma amine oxidase activity in vitro and in vivo.

Authors:  D S Robinson; W Lovenberg; H Keiser; A Sjoerdsma
Journal:  Biochem Pharmacol       Date:  1968-01       Impact factor: 5.858

4.  Multiple forms of monoamine oxidase in intact mitochondria as characterized by selective inhibitors and thermal stability: a comparison of eight mammalian species.

Authors:  R F Squires
Journal:  Adv Biochem Psychopharmacol       Date:  1972

5.  Some observations upon a new inhibitor of monoamine oxidase in brain tissue.

Authors:  J P Johnston
Journal:  Biochem Pharmacol       Date:  1968-07       Impact factor: 5.858

6.  Evidence that deprenyl, A type B monoamine oxidase inhibitor, is an indirectly acting sympathomimetic amine.

Authors:  L L Simpson
Journal:  Biochem Pharmacol       Date:  1978       Impact factor: 5.858

7.  Isoniazid and reaction to cheese.

Authors:  C K Smith; D T Durack
Journal:  Ann Intern Med       Date:  1978-04       Impact factor: 25.391

8.  Interactions between sympathomimetic amines and a new monoamine oxidase inhibitor.

Authors:  M H Lader; G Sakalis; M Tansella
Journal:  Psychopharmacologia       Date:  1970-08-19

9.  Deprenyl administration in man: a selective monoamine oxidase B inhibitor without the 'cheese effect'.

Authors:  J D Elsworth; V Glover; G P Reynolds; M Sandler; A J Lees; P Phuapradit; K M Shaw; G M Stern; P Kumar
Journal:  Psychopharmacology (Berl)       Date:  1978-04-14       Impact factor: 4.530

10.  Comparative behavioral effects of clorgyline and pargyline in man: a preliminary evaluation.

Authors:  S Lipper; D L Murphy; S Slater; M S Buchsbaum
Journal:  Psychopharmacology (Berl)       Date:  1979-04-11       Impact factor: 4.530

View more
  9 in total

1.  Pressor sensitivity to tyramine in patients with headache: relationship to platelet monoamine oxidase and to dietary provocation.

Authors:  R Peatfield; J T Littlewood; V Glover; M Sandler; F C Rose
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-09       Impact factor: 10.154

2.  Proceedings of the British Pharmacological Society. 9th-11th September 1985. Abstracts.

Authors: 
Journal:  Br J Pharmacol       Date:  1985-12       Impact factor: 8.739

3.  Relationship between tyramine potentiation and selective inhibition of monoamine oxidase types A and B in the rat vas deferens.

Authors:  J P Finberg; M Tenne
Journal:  Br J Pharmacol       Date:  1982-09       Impact factor: 8.739

4.  Tyramine-induced noradrenaline release from rat brain slices: prevention by (-)-deprenyl.

Authors:  V Glover; C J Pycock; M Sandler
Journal:  Br J Pharmacol       Date:  1983-09       Impact factor: 8.739

5.  High intake of dietary tyramine does not deteriorate glucose handling and does not cause adverse cardiovascular effects in mice.

Authors:  Christian Carpéné; Stéphane Schaak; Céline Guilbeau-Frugier; Josep Mercader; Jeanne Mialet-Perez
Journal:  J Physiol Biochem       Date:  2015-12-03       Impact factor: 4.158

6.  Is the failure of (-)deprenyl, a selective monoamine oxidase B inhibitor, to alleviate depression related to freedom from the cheese effect?

Authors:  N Mendis; C M Pare; M Sandler; V Glover; G M Stern
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

7.  The contribution of amphetamine metabolites of (-)-deprenyl to its antiparkinsonian properties.

Authors:  J D Elsworth; M Sandler; A J Lees; C Ward; G M Stern
Journal:  J Neural Transm       Date:  1982       Impact factor: 3.575

Review 8.  The MPTP Story.

Authors:  J William Langston
Journal:  J Parkinsons Dis       Date:  2017       Impact factor: 5.568

9.  Tranylcypromine isomers and Parkinson's disease: new aspects of an old drug.

Authors:  G P Reynolds; P Riederer; M Sandler
Journal:  J R Soc Med       Date:  1981-09       Impact factor: 18.000

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.